These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18348696)

  • 1. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation.
    Kawelke N; Bentmann A; Hackl N; Hager HD; Feick P; Geursen A; Singer MV; Nakchbandi IA
    J Bone Miner Res; 2008 Aug; 23(8):1278-86. PubMed ID: 18348696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
    Bentmann A; Kawelke N; Moss D; Zentgraf H; Bala Y; Berger I; Gasser JA; Nakchbandi IA
    J Bone Miner Res; 2010 Apr; 25(4):706-15. PubMed ID: 19821765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
    Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
    Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs.
    Monier-Faugere MC; Geng Z; Qi Q; Arnala I; Malluche HH
    J Bone Miner Res; 1996 Apr; 11(4):446-55. PubMed ID: 8992875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone formation in mice lacking apolipoprotein E.
    Schilling AF; Schinke T; Münch C; Gebauer M; Niemeier A; Priemel M; Streichert T; Rueger JM; Amling M
    J Bone Miner Res; 2005 Feb; 20(2):274-82. PubMed ID: 15647822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced proliferation and osteocalcin expression in osteoblasts of male idiopathic osteoporosis.
    Ruiz-Gaspà S; Blanch-Rubió J; Ciria-Recasens M; Monfort J; Tío L; Garcia-Giralt N; Nogués X; Monllau JC; Carbonell-Abelló J; Pérez-Edo L
    Calcif Tissue Int; 2010 Mar; 86(3):220-6. PubMed ID: 20101397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats.
    Zhao Y; Zou B; Shi Z; Wu Q; Chen GQ
    Biomaterials; 2007 Jul; 28(20):3063-73. PubMed ID: 17418401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
    Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
    Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis.
    Eastell R; Dickson ER; Hodgson SF; Wiesner RH; Porayko MK; Wahner HW; Cedel SL; Riggs BL; Krom RA
    Hepatology; 1991 Aug; 14(2):296-300. PubMed ID: 1860685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle.
    McDonald AC; Schuijers JA; Gundlach AL; Grills BL
    Bone; 2007 Apr; 40(4):895-903. PubMed ID: 17157570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.